Abstract
SPECIALTY GRAND CHALLENGE article Front. Vet. Sci., 13 September 2016Sec. Veterinary Pharmacology and Toxicology Volume 3 - 2016 | https://doi.org/10.3389/fvets.2016.00082
Highlights
Veterinary pharmacology and toxicology are being increasingly recognized as important disciplines and were rapidly changing and evolving in the mid-twentieth century
By the mid-1950s, pharmacology and toxicology were a highly active area of veterinary medicine; veterinary pharmacology and toxicology emerged as new disciplines, closely related, because they were involved in developing new compound, new antimicrobials and antiparasitics to control infection diseases, and analgesic/non-steroidal anti-inflammatory drugs affecting different animal species
The following new antimicrobial active substances have been authorized for use in veterinary medicine: difloxacin, valnemulin, pirlimycin, tulathromycin, tylvalosin, ceftiofur, cefovecin, gamithromycin, pradofloxacin, and tildipirosin
Summary
The antiparasitic, analgesics, antiobesity, cardiovascular, and anticancer drug market for dogs and cats has grown abundantly, which has been the result of the progress of the veterinary pharmacology and toxicology In both fields of veterinary medicine (i.e., domestic and companion animals, and wild/exotic animals) was strengthened as observation-based medical practice was complemented and, supplemented by sciencebased medicine. The challenge for pharmacologists and toxicologists is to consider, from among this array of opportunities, which biomarkers are sufficiently well validated with regard to their linkage to diseases and sufficiently reasonable in cost to warrant their use in exposure–response studies This includes consideration of the new and highly sophisticated genomic tools.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
